Christopher J. Recklitis, PhD, MPH, on The Risk of Suicide After a Cancer Diagnosis
2015 IPOS APOS World Congress of Psycho-Oncology
Christopher J. Recklitis, PhD, MPH, of the Dana-Farber Cancer Institute, discusses what is known about suicide after cancer, the risks faced by prostate cancer patients within the first year after diagnosis, and challenges across the treatment trajectory
Related Videos
Wendy Lichtenthal, PhD, and David Kissane, MD
Wendy Lichtenthal, PhD, of Memorial Sloan Kettering Cancer Center, and David Kissane, MD, of Monash University, discuss the importance of and challenges with attending to the whole family during palliative care.
Allison J. Applebaum, PhD, and William S. Breitbart, MD
Allison J. Applebaum, PhD, and William S. Breitbart, MD, of Memorial Sloan Kettering Cancer Center, discuss the early days of this new treatment for despair and distress in cancer patients.
Allison J. Applebaum, PhD, and William S. Breitbart, MD
Allison J. Applebaum, PhD, and William S. Breitbart, MD, of Memorial Sloan Kettering Cancer Center, explain how they brought this new treatment to help stressed caregivers of loved ones with cancer.
Jimmie C. Holland, MD, and Tammy A. Schuler, PhD
Jimmie C. Holland, MD, of Memorial Sloan Kettering Cancer Center, and Tammy A. Schuler, PhD, of the Association for Behavioral and Cognitive Therapies, demonstrate a dialogue between a clinician and a recently diagnosed cancer patient whose distress was discovered with the use of the Distress Thermometer.
Bradley J. Zebrack, PhD and Ursula Sansom-Daly, PhD
Bradley J. Zebrack, PhD, of the University of Michigan School of Social Work, and Ursula Sansom-Daly, PhD, of the University of New South Wales, talk about providing supportive care services that meet the unique needs of adolescents and young adults with cancer.